Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03126110 |
|---|---|
| Brief Title: | Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies |
| First Submitted : | April 19, 2017 |
| First Submitted that Met QC Criteria : | April 21, 2017 |
| First Posted : | April 24, 2017 |
| Last Update Submitted that Met QC Criteria : | July 17, 2020 |
| Last Update Posted : | July 21, 2020 |